SciELO - Scientific Electronic Library Online

vol.35 issue2Chemotherapy agents and cardiotoxicity: a current and user-friendly approach for the clinician, a developing disciplineRhabdomyolysis and acute kidney failure associated with the use of cocaine and vigorous exercice author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand



Related links


Archivos de Medicina Interna

Print version ISSN 0250-3816On-line version ISSN 1688-423X


VIROGA, Stephanie; LOPEZ, Maynés  and  TAMOSIUNAS, Gustavo. Gastrointestinal drugs safey in pregnancy. Arch. Med Int [online]. 2013, vol.35, n.2, pp.49-54. ISSN 0250-3816.

ABSTRACT: Arch Med Interna 2013 - 35(2):49-54 Pregnant women are considered a risk population in terms of the use of drugs. The incidence of congenital defects in the general population is 2-4%, and less than 1% may be attributed to drugs. The issue is that most drugs have an undetermined risk, given the limitations of evidence during pregnancy and breastfeeding. The use of gastrointestinal drugs is very widespread in the general population, as well as during pregnancy. The paper reviews the fetal/neonatal safety of antiemetics, antacids, proton pump inhibitors, H2 histamine receptor antagonists and drugs used in the therapy of intestinal inflammatory disease.

Keywords : Gastrointestinal drugs; Pregnancy; Fetal risk.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License